198 related articles for article (PubMed ID: 24913022)
1. Systematic review and meta-analysis of Meniett therapy for Meniere's disease.
Ahsan SF; Standring R; Wang Y
Laryngoscope; 2015 Jan; 125(1):203-8. PubMed ID: 24913022
[TBL] [Abstract][Full Text] [Related]
2. Positive pressure therapy for Ménière's disease or syndrome.
van Sonsbeek S; Pullens B; van Benthem PP
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD008419. PubMed ID: 25756795
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
Rajan GP; Din S; Atlas MD
J Laryngol Otol; 2005 May; 119(5):391-5. PubMed ID: 15949105
[TBL] [Abstract][Full Text] [Related]
4. Meniett Therapy for Ménière's Disease: An Updated Meta-analysis.
Zhang SL; Leng Y; Liu B; Shi H; Lu M; Kong WJ
Otol Neurotol; 2016 Mar; 37(3):290-8. PubMed ID: 26808558
[TBL] [Abstract][Full Text] [Related]
5. Long-term effect of transtympanic intermittent pressure therapy using a tympanic membrane massage device for intractable meniere's disease and delayed endolymphatic hydrops.
Shojaku H; Takakura H; Asai M; Fujisaka M; Ueda N; Do TA; Tsubota M; Watanabe Y
Acta Otolaryngol; 2021 Nov; 141(11):977-983. PubMed ID: 34689678
[TBL] [Abstract][Full Text] [Related]
6. Meniett device in meniere disease: Randomized, double-blind, placebo-controlled multicenter trial.
Russo FY; Nguyen Y; De Seta D; Bouccara D; Sterkers O; Ferrary E; Bernardeschi D
Laryngoscope; 2017 Feb; 127(2):470-475. PubMed ID: 27515294
[TBL] [Abstract][Full Text] [Related]
7. Functional outcome of treatment of Ménière's disease with the Meniett pressure generator.
Stokroos R; Olvink MK; Hendrice N; Kingma H
Acta Otolaryngol; 2006 Mar; 126(3):254-8. PubMed ID: 16618650
[TBL] [Abstract][Full Text] [Related]
8. Positive pressure therapy for Meniere's syndrome/disease with a Meniett device: a systematic review of randomised controlled trials.
Syed MI; Rutka JA; Hendry J; Browning GG
Clin Otolaryngol; 2015 Jun; 40(3):197-207. PubMed ID: 25346252
[TBL] [Abstract][Full Text] [Related]
9. The Clinical Benefit of Device Therapy for Meniere's Disease in Adults: Systematic Review and Meta-Analysis.
Wang SJ; Yang H; Yao YY; Gu HY; Lin LL; Zhang C; Luo J
J Int Adv Otol; 2019 Apr; 15(1):121-129. PubMed ID: 31058601
[TBL] [Abstract][Full Text] [Related]
10. Effects of transtympanic intermittent pressure therapy using a new tympanic membrane massage device for intractable Meniere's disease and delayed endolymphatic hydrops: a prospective study.
Shojaku H; Aoki M; Takakura H; Fujisaka M; Asai M; Tsubota M; Ito Y; Watanabe Y
Acta Otolaryngol; 2021 Oct; 141(10):907-914. PubMed ID: 34520288
[TBL] [Abstract][Full Text] [Related]
11. In response to systematic review and meta-analysis of Meniett therapy for Meniere's disease.
Ahsan SF; Wang Y
Laryngoscope; 2015 Dec; 125(12):E391. PubMed ID: 25994452
[No Abstract] [Full Text] [Related]
12. In reference to systematic review and meta-analysis of Meniett therapy for Meniere's disease.
Syed MI; Rutka J
Laryngoscope; 2015 Dec; 125(12):E390. PubMed ID: 25993911
[No Abstract] [Full Text] [Related]
13. Initial UK experience of patient satisfaction with the Meniett® device for Ménière's disease treatment.
Buchanan MA; Rai A; Prinsley PR
J Laryngol Otol; 2010 Oct; 124(10):1067-72. PubMed ID: 20537216
[TBL] [Abstract][Full Text] [Related]
14. Clinical long-term effects of surgical treatment for intractable Meniere's disease: a more than 13-year follow-up after pressure treatment and further surgical treatment for intractable vertigo.
Liu F; Huang W; Chen K
Acta Otolaryngol; 2019 Dec; 139(12):1053-1057. PubMed ID: 31556757
[No Abstract] [Full Text] [Related]
15. Meniett clinical trial: long-term follow-up.
Gates GA; Verrall A; Green JD; Tucci DL; Telian SA
Arch Otolaryngol Head Neck Surg; 2006 Dec; 132(12):1311-6. PubMed ID: 17178941
[TBL] [Abstract][Full Text] [Related]
16. Intermittent pressure therapy of intractable Ménière's disease using the Meniett device: a preliminary report.
Gates GA; Green JD
Laryngoscope; 2002 Aug; 112(8 Pt 1):1489-93. PubMed ID: 12172267
[TBL] [Abstract][Full Text] [Related]
17. The effects of transtympanic micropressure treatment in people with unilateral Meniere's disease.
Gates GA; Green JD; Tucci DL; Telian SA
Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):718-25. PubMed ID: 15210552
[TBL] [Abstract][Full Text] [Related]
18. The effect of the Meniett device in patients with Ménière's disease: long-term results.
Dornhoffer JL; King D
Otol Neurotol; 2008 Sep; 29(6):868-74. PubMed ID: 18617868
[TBL] [Abstract][Full Text] [Related]
19. Intermittent pressure therapy of intractable Meniere's disease and delayed endolymphatic hydrops using the transtympanic membrane massage device: a preliminary report.
Watanabe Y; Shojaku H; Junicho M; Asai M; Fujisaka M; Takakura H; Tsubota M; Yasumura S
Acta Otolaryngol; 2011 Nov; 131(11):1178-86. PubMed ID: 21838607
[TBL] [Abstract][Full Text] [Related]
20. Effect of transtympanic low-pressure therapy in patients with unilateral Menière's disease unresponsive to betahistine: a randomised, placebo-controlled, double-blinded, clinical trial.
Gürkov R; Filipe Mingas LB; Rader T; Louza J; Olzowy B; Krause E
J Laryngol Otol; 2012 Apr; 126(4):356-62. PubMed ID: 22365373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
